Estrogen Receptor β Isoforms Exhibit Differences in Ligand-Activated Transcriptional Activity in an Estrogen Response Element Sequence-Dependent Manner

Endocrinology

Volumn 145, Issue 1, 2004, Pages 149-160

  Ramsey, Timothy L ^a   Risinger, Kelly E ^a   Jernigan, Sarah C ^a   Mattingly, Kathleen A ^a   Klinge, Carolyn M ^a,b  

^a University of Louisville School of Medicine   (United States)

^b Department of Biochemistry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BIS(4 HYDROXYPHENYL)PROPIONITRILE; CYCLIC AMP; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA1; ISOENZYME; PROPIONITRILE; RESVERATROL; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHO CELLS; CRICETINAE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; HUMANS; ISOMERISM; LIGANDS; RATS; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; STILBENES; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 0347089135     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1043     Document Type: Article

References (72)

1. Couse JF, Korach KS 1999 Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20:358-417
2. Henderson BE, Feigelson HS 2000 Hormonal carcinogenesis. Carcinogenesis 21:427-433
3. Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA, Sutherland RL 2001 Frequent loss of estrogen receptor-β expression in prostate cancer. Cancer Res 61:5331-5335
4. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A 1996 Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
5. Kuiper GG, Carlsson B, Grandien J, Enmark E, Haggblad J, Nilsson S, Gustafsson J-A 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138: 863-870
6. Pike AC, Brzozowski AM, Hubbard RE 2000 A structural biologist's view of the oestrogen receptor. J Steroid Biochem Mol Biol 74:261-268
7. Metivier R, Petit FG, Valotaire Y, Pakdel F 2000 Function of N-terminal transactivation domain of the estrogen receptor requires a potential α-helical structure and is negatively regulated by the A domain. Mol Endocrinol 14: 1849-1871
8. Delaunay F, Pettersson K, Tujague M, Gustafsson JA 2000 Functional differences between the amino-terminal domains of estrogen receptors α and β Mol Pharmacol 58:584-590
9. Warnmark A, Wikstrom A, Wright APH, Gustafsson J-A, Hard T 2001 The N-terminal regions of estrogen receptor α and β are unstructured in vitro and show different TBP binding properties. J Biol Chem 276:45939-45944
10. Safe S 2001 Transcriptional activation of genes by 17 β-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 62:231-252
11. Webb P, Lopez GN, Uht RM, Kushner PJ 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway. Mol Endocrinol 9:443-456
12. Klinge CM 2000 Estrogen receptor interaction with co-activators and corepressors. Steroids 65:227-251
13. Klinge CM 1999 Estrogen receptor binding to estrogen response elements slows ligand dissociation and synergistically activates reporter gene expression. Mol Cell Endocrinol 150:99-111
14. Klinge CM, Jernigan SC, Smith SL, Tyulmenkov VV, Kulakosky PC 2001 Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor α. Mol Cell Endocrinol 174:151-166
15. Ramsey TL, Klinge CM 2001 Estrogen response element binding induces alterations in estrogen receptor a conformation as revealed by susceptibility to partial proteolysis. J Mol Endocrinol 27:275-292
16. Wood JR, Greene GL, Nardulli AM 1998 Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol Cell Biol 18:1927-1934
17. Wood JR, Likhite VS, Loven MA, Nardulli AM 2001 Allosteric modulation of estrogen receptor conformation by different estrogen response elements. Mol Endocrinol 15:1114-1126
18. Scobie GA, Macpherson S, Millar MR, Groome NP, Romana PG, Saunders PT 2002 Human oestrogen receptors: differential expression of ERα and ßand the identification of ERβ variants. Steroids 67:985-992
19. Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Home EL, Su JL, Kliewer SA, Lehmann JM, Willson TM 1998 Cloning and characterization of human estrogen receptor β isoforms. Biochem Biophys Res Commun 247: 75-78
20. Fuqua SA, Schiff R, Parra I, Friedrichs WE, Su JL, McKee DD, Slentz-Kesler K, Moore LB, Willson TM, Moore JT 1999 Expression of wild-type estrogen receptor β and variant isoforms in human breast cancer. Cancer Res 59:5425-5428.
21. Denger S, Reid G, Brand H, Kos M, Gannon F 2001 Tissue-specific expression of human ERα and ERβ in the male. Mol Cell Endocrinol 178:155-160
22. Wilkinson HA, Dahllund J, Liu H, Yudkovitz J, Cai S-J, Nilsson S, Schaeffer JM, Mitra SW 2002 Identification and characterization of a functionally distinct form of human estrogen receptor β. Endocrinology 143:1558-1561
23. Cheung E, Schwabish MA, Kraus WL 2003 Chromatin exposes intrinsic differences in the transcriptional activities of estrogen receptors α and β. EMBO J 22:600-611
24. Xu L, Pan-Hammarstrom Q, Forsti A, Hemminki K, Hammarstrom L, Labuda D, Gustafsson JA, Dahlman-Wright K 2003 Human estrogen receptor β 548 is not a common variant in three distinct populations. Endocrinology 144: 3541-3546
25. Ashby J, Tinwell H, Pennie W, Brooks AN, Lefevre PA, Beresford N, Sumpter JP 1999 Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects. J Appl Toxicol 19:39-45
26. Cowley SM, Parker MG 1999 A comparison of transcriptional activation by ER α and ER β. J Steroid Biochem Mol Biol 69:165-175
27. Hall JM, McDonnell DP 1999 The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140:5566-5578
28. Jones PS, Parrott E, White IN 1999 Activation of transcription by estrogen receptor α and β is cell type-and promoter-dependent. J Biol Chem 274: 32008-32014
29. Flouriot G, Brand H, Denger S, Metivier R, Kos M, Reid G, Sonntag-Buck V, Gannon F 2000 Identification of a new isoform of the human estrogen receptor-α (hER-α) that is encoded by distinct transcripts and that is able to repress hER-α activation function 1. EMBO J 19:4688-4700
30. Bhat RA, Harnish DC, Stevis PE, Lyttle CR, Komm BS 1998 A novel human estrogen receptor β: identification and functional analysis of additional N-terminal amino acids. J Steroid Biochem Mol Biol:233-240
31. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM 2000 Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β. Endocrinology 141:3657-3667
32. Reese JC, Katzenellenbogen BS 1991. Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor. Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands. J Biol Chem 266:10880-10887
33. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M, Gustafsson JA 1997 Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 82:4258-4265
34. Klinge CM, Silver BF, Driscoll MD, Sathya G, Bambara RA, Hilf R 1997 COUP-TF interacts with estrogen receptor, binds to estrogen response elements and half-sites, and modulates estrogen-induced gene expression. J Biol Chem 272:31465-31474
35. Kulakosky PC, Jernigan SC, McCarty MA, Klinge CM 2002 Response element sequence regulates estrogen receptor α and ß affinity and activity. J Mol Endocrinol 29:137-152
36. Verma RS, Giannola D, Shlomchik W, Emerson SG 1998 Increased efficiency of liposome-mediated transfection by volume reduction and centrifugation. Biotechniques 25:46-49
37. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA 2001 Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44:4230-4251
38. Pavlik EJ, Coulson PB 1976 Hydroxylapatite "batch" assay for estrogen receptor: increased sensitivity over present receptor assays. J Steroid Biochem 7:357-368
39. Choi I, Ko C, Park-Sarge O, Nie R, Hess RA, Graves C, Katzenellenbogen BS 2001 Human estrogen receptor β-specific monoclonal antibodies: characterization and use in studies of estrogen receptor β protein expression in reproductive tissues. Mol Cell Endocrinol 181:139-150
40. Tyulmenkov VT, Klinge CM 2000 Interaction of tetrahydrocrysene ketone with estrogen receptors α and β indicates conformational differences in the receptor subtypes. Arch Biochem Biophys 381:135-142
41. Kulakosky PC, Klinge CM 2003 Maximizing production of estrogen receptor β with the baculovirus expression system. Biotechniques 34:334-343
42. Tyulmenkov VV, Klinge CM 2001 A mathematical approach to predict the affinity of estrogen receptors α and β binding to DNA. Mol Cell Endocrinol 182:109-119
43. Klinge CM, Peale Jr FV, Hilf R, Bambara RA, Zain S 1992 Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro. Cancer Res 52:1073-1081
44. Klinge CM, Bodenner DL, Desai D, Niles RM, Traish AM 1997 Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro. Nucleic Acids Res 25:1903-1912
45. Klinge CM, Studinski-Jones AL, Kulakosky PC, Bambara RA, Hilf R 1998 Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements. Mol Cell Endocrinol 143:79-90
46. Klinge CM 1999 Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF). J Steroid Biochem Molec Biol 71:1-19
47. Barsalou A, Gao W, Anghel SI, Carriere J, Mader S 1998 Estrogen response elements can mediate agonist activity of anti-estrogens in human endometrial Ishikawa cells. J Biol Chem 273:17138-17146
48. Kuiper GG, Lemmen JG, Carlsson B, Corton J, Safe SH, van der Saag P, van der Burg B, Gustafsson JA 1998 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139:4252-4263
49. McInerney EM, Weis KE, Sun J, Mosselman S, Katzenellenbogen BS 1998 Transcription activation by the human estrogen receptor subtype β (ER β) studied with ER β and ER α receptor chimeras. Endocrinology 139:4513-4522
50. Tcherepanova I, Puigserver P, Norris JD, Spiegelman BM, McDonnell DP 2000 Modulation of estrogen receptor-α transcriptional activity by the coactivator PGC-1. J Biol Chem 275:16302-16308
51. Metivier R, Penot G, Flouriot G, Pakdel F 2001 Synergism between ERα transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 α-helical core and for a direct interaction between the N- and C-terminal domains. Mol Endocrinol 15:1953-1970
52. Saville B, Poukka H, Wormke M, Janne OA, Palvimo JJ, Stoner M, Samudio I, Safe S 2002 Cooperative coactivation of estrogen receptor α in ZR-75 human breast cancer cells by SNURF and TATA-binding protein. J Biol Chem 277: 2485-2497
53. Tyulmenkov VT, Jernigan SC, Klinge CM 2000 Comparison of transcriptional synergy of estrogen receptors α and β from multiple tandem estrogen response elements. Mol Cell Endocrinol 165:151-161
54. Saji S, Jensen EV, Nilsson S, Rylander T, Warner M, Gustafsson JA 2000 Estrogen receptors α and β in the rodent mammary gland. Proc Natl Acad Sci USA 97:337-342
55. Peng B, Lu B, Leygue E, Murphy LC 2003 Putative functional characteristics of human estrogen receptor-β isoforms. J Mol Endocrinol 30:13-29
56. Bhat KPL, Kosmeder 2nd JW, Pezzuto JM 2001 Biological effects of resveratrol. Antioxid Redox Signal 3:1041-1064
57. Huang C, Ma WY, Goranson A, Dong Z 1999 Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20:237-242
58. Klinge CM 2001 Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29:2905-2919
59. Tyulmenkov W, Klinge CM 2001 Estrogen receptors α and β exhibit different estradiol and estrogen response element binding in the presence of nonspecific DNA. Arch Biochem Biophys 390:253-264
60. Berry M, Nunez AM, Chambon P 1989 Estrogen responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc Natl Acad Sci USA 86:1218-1222
61. Weisz A, Bresciani F 1988 Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol Endocrinol 2:816-824
62. Weisz A, Rosales R 1990 Identification of an estrogen response element up-stream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res 18:5097-5106
63. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P 1990 Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9:1603-1614
64. Tremblay A, Giguere V 2001 Contribution of steroid receptor coactivator-1 and CREB binding protein in ligand-independent activity of estrogen receptor β. J Steroid Biochem Mol Biol 77:19-27
65. Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA, Katzenellenbogen BS 2002 Antagonists selective for estrogen receptor α. Endocrinology 143:941-947
66. Wong CW, Komm B, Cheskis BJ 2001 Structure-function evaluation of ER α and β interplay with SRC family coactivators. ER selective ligands. Biochemistry 40:6756-6765
67. Kobayashi Y, Kitamoto T, Masuhiro Y, Watanabe M, Kase T, Metzger D, Yanagisawa J, Kato S 2000 p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor α and β by interacting directly with the N-terminal A/B domains. J Biol Chem 275:15645-15651
68. Wingender E, Chen X, Fricke E, Geffers R, Hehl R, Liebich I, Krull M, Matys V, Michael H, Ohnhauser R, Pruss M, Schacherer F, Thiele S, Urbach S 2001 The TRANSFAC system on gene expression regulation. Nucleic Acids Res 29:281-283
69. Metivier R, Gay FA, Hubner MR, Flouriot G, Salbert G, Gannon F, Kah O, Pakdel F 2002 Formation of an hER α-COUP-TFI complex enhances hER α AF-1 through Ser118 phosphorylation by MAPK. EMBO J 21:3443-3453
70. Metivier R, Stark A, Flouriot G, Hubner MR, Brand H, Penot G, Manu D, Denger S, Reid G, Kos M, Russell RB, Kah O, Pakdel F, Gannon F 2002 A dynamic structural model for estrogen receptor-α activation by ligands, emphasizing the role of interactions between distant A and E domains. Mol Cell 10:1019-1032
71. Coleman KM, Dutertre M, El-Gharbawy A, Rowan BG, Weigel NL, Smith CL 2003 Mechanistic differences in the activation of estrogen receptor-α (ERα)-and ERβ-dependent gene expression by cAMP signaling pathway(s). J Biol Chem 278:12834-12845
72. Klinge CM, Risinger KE, Watts MB, Beck V, Eder R, Jungbauer A 2003 Estrogenic activity in white and red wine extracts. J Agric Food Chem 51:1850-1857